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Recent evidence that vacuolar enzymes in yeast can be
delivered directly from the cytosol, rather than via the
secretory pathway, alerts us to the increasing evidence
for ‘non-classical’ forms of protein translocation that
may involve ABC transporters.
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Signal-mediated translocation of proteins occurs across
the membranes of several organelles, including the endo-
plasmic reticulum (ER), peroxisomes, mitochondria and
lysosomes. In some cases, signal-mediated translocation
involves a well-characterized molecular machine — or
translocon — such as the Sec61 complex in the ER. In
parallel with these systems, several membranes also have
members of the ATP-binding-cassette (ABC) protein
family (Fig. 1), transporters that are capable of trans-
locating a variety of substrates across membranes, includ-
ing peptides and proteins [1]. The recent discovery that
some enzymes are translocated directly from the cyto-
plasm into the vacuole in yeast [2,3] prompts a re-
examination of these alternative routes of transport that
do not use the conventional signal-peptide-mediated
mechanisms.
Transport across organelle membranes
The molecular machinery responsible for signal-mediated
protein translocation across the ER membrane is well
known [4]. In addition to this ‘classical’ translocation
machinery, the ER also contains the TAP1–TAP2 (trans-
porter associated with antigen presentation) heterodimer
that transports peptides from the cytosol into the ER
lumen, in an ATP-dependent manner. There, the pep-
tides assemble with class I major histocompatibility
complex (MHC) molecules for presentation to cells of the
immune system [5]. TAP1 and TAP2 are members of the
ABC family and are each a ‘half transporter’, consisting of
a membrane-spanning domain (with six transmembrane
regions) and an ATP-binding domain. Expression of
TAP1 and TAP2 in insect cells showed that the
TAP1–TAP2 complex requires no additional cofactors to
function as a peptide transporter [6]. The TAP complex
acts as a selective peptide pump, because human, rat and
mouse TAP1–TAP2 complexes have been shown to
display some specificity for peptide substrates [7].
In the case of the peroxisome, several pathways for the
import of proteins are known. Targeting signals have been
identified in proteins destined for peroxisomes, and recep-
tors for the PTS1 and PTS2 signals have been identified.
The corresponding translocon, however, remains
unknown. Peroxisomal membranes contain two members
of the ABC family, PMP70 [8] and ALDP [9], which, like
Figure 1
Examples of ABC transporters located in the
organelle membranes of eukaryotic cells. A
typical ABC transporter consists of two
transmembrane domains that each span the
bilayer six times and two ATP-binding
domains. The transporters can be assembled
from two half-transporter polypeptides or may
be synthesized as a single polypeptide chain.
See text for further details.
TAP1 and TAP2, are half transporters. PMP70 and ALDP
may form both homodimers and heterodimers. 
Mutations in PMP70 are found in a subset a patients with
Zellweger syndrome, a human disease in which mature
peroxisomes are absent and the activities of all peroxiso-
mal enzymes are deficient [10]. Mutations in ALDP cause
adrenoleukodystrophy (ALD), a severe peroxisomal disor-
der associated with the accumulation of very long-chain
fatty acids (VLCFA), possibly due to a defect in the
import of VLCFA acyl-CoA synthetase into peroxisomes
[11]. The functions of PMP70 and ALDP are not known,
although it has been suggested that they may function as
protein transporters in the peroxisomal membrane. An
ALDP homolog in the yeast Saccharomyces cerevisiae,
Pxa1p, is also localized to peroxisomes. 
Proteins can be delivered to lysosomes — or their equiva-
lent in yeast, the vacuole — via the secretory or endocytic
pathways, and by autophagocytosis. In addition to these
vesicular pathways, lysosomal proteins can also be
imported directly from the cytosol. This uptake is medi-
ated by the peptide motif KFERQ, which is recognized
by the heat-shock protein (Hsp) 70 family member Prp73
[12]. Direct import of the vacuolar protein aminopeptidase
I (API) is believed to be mediated by its amino-terminal
16 amino acids [3]. The machinery for direct vacuolar
targeting is still unknown, but mutants defective in the
import of API have been isolated [2]. The ABC trans-
porter HMT1p is localized to the vacuole in the fission
yeast Schizosaccharomyces pombe, and has been demon-
strated to be an ATP-dependent transporter of phyto-
chelatins, which are peptide–Cd2+ complexes involved in
heavy metal tolerance [13].
Most proteins that are imported from the cytosol into the
mitochondria contain an amino-terminal signal sequence,
and the machinery responsible for the targeting and
translocation of these proteins across the outer  and inner
mitochondrial membranes has been identified [14]. In
addition to the classical, signal-mediated import machin-
ery, an ABC-family member, Atm1p, is located in the
mitochondrial inner membrane [15]. Although the ATM1
gene is required for normal growth in yeast, the function
of Atm1p remains unclear.
Eukaryotic and prokaryotic cell membranes
In addition to classical, vesicle-mediated protein secre-
tion, across the plasma membrane, ‘non-classical’ secre-
tion also occurs . Yeast Ste6p is an ABC protein that is
transiently located in the plasma membrane and is known
to be the transporter for the lipopeptide a-factor mating
pheromone [16]. Ste6p is homologous to the mammalian
multidrug resistance transporters (MDRs), one of which,
MDR1, is found in the plasma membrane and is known to
transport amphiphilic cytotoxic drugs out of cells [17].
There is evidence that MDRs can also function as peptide
transporters: for example, mouse MDR3, when expressed
in yeast, can transport a-factor at a low efficiency [18], and
there is evidence that MDR1 can transport many
hydrophobic peptides [19].
Bacteria possess many ABC transporters [1] in addition to
having a classical protein secretion route that is mediated
by SecA and shows similarities to ER transport in eukary-
otes [20]. Bacterial ABC proteins transport a variety of sub-
strates, including amino acids, peptides and sugars.
Eukaryotic ABC transporters are known to transport pep-
tides but, so far as we know, they do not transport proteins.
Bacterial ABC transporters, by contrast, export a variety of
proteins, mostly toxins and some as large as 177 kDa.
Non-classical protein export from mammalian cells
Mammalian cells produce a variety of proteins that lack a
secretory signal sequence yet are exported from cells by
non-classical mechanisms [21–24]. Examples of such pro-
teins include interleukin-1b [23], basic fibroblast growth
factor [25] and thioredoxin [23]. Pharmacological agents,
such as monensin or brefeldin A, that perturb the function
of the Golgi complex do not block secretion of these pro-
teins, and export is enhanced by a variety of drugs that
increase synthesis of heat-shock proteins. 
Given the many examples of direct transport of peptides
or proteins across organellar membranes, it is not surpris-
ing that some proteins in mammalian cells are directly
exported from the cytosol across the plasma membrane.
Non-classical export is not limited to specialized or
damaged cells since it occurs in normal as well as neoplas-
tic cells. Furthermore, we have recently shown that yeast
also possesses the machinery for the non-classical secre-
tion of proteins in addition to the a-factor peptide trans-
porter, Ste6p (unpublished data). Since the mechanism of
non-classical protein export in mammalian cells remains
unknown, our yeast system may provide the first mecha-
nistic insight into non-classical protein secretion in
eukaryotic cells.
The normal housekeeping function of non-classical
protein export from mammalian cells may be to remove
toxic proteins, or simply to control the levels of normal
cytosolic proteins. Through the course of evolution, these
exported cytosolic enzymes might have acquired extra-
cellular roles. This possibility is illustrated by the non-
classical export of thioredoxin, an intracellular
disulfide-reducing enzyme [23], in that adult T-cell-
leukemia-derived factor, the secreted form of thioredoxin,
upregulates the expression of the interleukin-2 receptor in
an autocrine fashion [26]. Non-classical export of cytosolic
proteins might even explain in part why some intracellular
proteins are implicated in autoimmune disease: epitopes
of certain cytosolic proteins, such as ribosomal P-proteins,
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presented on the cell surface are the targets of autoanti-
bodies, and cell lysis or damage seems an unsatisfactory
explanation for the appearance of these cytosolic proteins
at the cell surface [27,28]. 
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